Latest posts by Yvonne Villante (see all)
- Does the Healthy Indiana Plan 2.0 have national aspirations? - February 6, 2018
- 10 States move to impose Medicaid work requirements; Kentucky HEALTH becomes first to implement - January 18, 2018
- Alex Azar on track to become next HHS Secretary - January 10, 2018
Following yesterday’s Senate Finance Committee hearing, it appears Alex Azar, the former head of Pharmaceutical company Eli Lilly’s U.S. operation, is on track to be confirmed as the Head of the Department of Health and Human Services (HHS). If confirmed, Azar will replace Thomas Price M.D., a former congressman who served as the HHS secretary for seven months before resigning.
Despite a probe by Democrats, including that from Sen. Ron Wyden (D-Oregon), on his drug industry ties, Republicans have focused on the fact that Azar would come to the job with greater working knowledge of the sprawling agency, with its budget of more than $1.1 trillion and far-flung staff of nearly 80,000, than many of his predecessors, according to the Washington Post.